deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT03486197

Neutron Radiation Therapy and Pembrolizumab in Treating Participants With Advanced Urothelial Carcinoma

Phase II Trial of Neutron Radiotherapy With Concurrent Checkpoint Inhibitor Immunotherapy (Pembrolizumab) in Patients With Advanced Urothelial Carcinoma

Sponsor: University of Washington

Conditions Urothelial Carcinoma
Interventions Laboratory Biomarker Analysis Pembrolizumab Radiation Therapy
Updated 20 times since 2018 Last updated: Oct 29, 2024 Started: Jan 17, 2019 Primary completion: Nov 1, 2023 Completion: May 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Closed per SRC Low Accrual Policy

Other terminated trials from University of Washington

See all terminations from University of Washington

Other Urothelial Carcinoma trials with similar outcome

Browse all Urothelial Carcinoma trials

Listed as NCT03486197, this PHASE2 trial focuses on Urothelial Carcinoma and remains terminated or withdrawn. Sponsored by University of Washington, it has been updated 20 times since 2019, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~May 2018 – ~Dec 2018 · 7 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Jun 2019 · 3 months · monthly snapshot~Jun 2019 – ~May 2020 · 11 months · monthly snapshot~May 2020 – ~Jul 2020 · 2 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Jan 2022 · 4 months · monthly snapshot~Jan 2022 – ~Jul 2022 · 6 months · monthly snapshot~Jul 2022 – ~Feb 2023 · 7 months · monthly snapshot~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshot~Mar 2023 – ~Sep 2023 · 6 months · monthly snapshot~Sep 2023 – ~Dec 2023 · 3 months · monthly snapshot~Dec 2023 – ~Jun 2024 · 6 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – present · 19 months · monthly snapshot

Change History

20 versions recorded

  1. Dec 2024 — Present [monthly]

    Terminated PHASE2

  2. Sep 2024 — Dec 2024 [monthly]

    Terminated PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  4. Jun 2024 — Jul 2024 [monthly]

    Terminated PHASE2

    Status: Active Not Recruiting → Terminated

  5. Dec 2023 — Jun 2024 [monthly]

    Active Not Recruiting PHASE2

▶ Show 15 earlier versions

  1. Sep 2023 — Dec 2023 [monthly]

    Active Not Recruiting PHASE2

  2. Mar 2023 — Sep 2023 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  3. Feb 2023 — Mar 2023 [monthly]

    Recruiting PHASE2

  4. Jul 2022 — Feb 2023 [monthly]

    Recruiting PHASE2

  5. Jan 2022 — Jul 2022 [monthly]

    Recruiting PHASE2

  6. Sep 2021 — Jan 2022 [monthly]

    Recruiting PHASE2

  7. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE2

  8. Jul 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

    Status: Suspended → Recruiting

  9. May 2020 — Jul 2020 [monthly]

    Suspended PHASE2

    Status: Recruiting → Suspended

  10. Jun 2019 — May 2020 [monthly]

    Recruiting PHASE2

  11. Mar 2019 — Jun 2019 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  12. Feb 2019 — Mar 2019 [monthly]

    Not Yet Recruiting PHASE2

  13. Jan 2019 — Feb 2019 [monthly]

    Not Yet Recruiting PHASE2

  14. Dec 2018 — Jan 2019 [monthly]

    Not Yet Recruiting PHASE2

  15. May 2018 — Dec 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Washington
Data source: University of Washington

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations